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Titik Pemesanan Ulang; 
Stok Pengaman; 
 Cardiovascular disease was still a global threat and give a major role as the number 
one cause of death in the world. Patients with CVDs should take the medication 
regularly so that the availability of these drugs in health facilities must be maintained. 
And then, Cardiovascular drugs were the highest usage costs during 2019, which is 
around Rp. 6,924,415,718.20 (22.62%) so that it requires special attention to control 
the inventory. The object of this research was to determine the implementation of 
cardiovascular drug inventory control using ABC-EOQ-ROP-SS method to minimize 
the stock inventory, while maintaining the service level. This research used a non-
experimental comparative method with retrospective cardiovascular drug data 
collection in 2019. Data obtained through the documentation of the Pharmacy 
Installation section and the logistics section. The data were analyzed to determine the 
cost efficiency of cardiovascular drugs using the ABC-EOQ-ROP-SS method compared 
to actual data for drug orders in January-December 2019 .The results of ABC-EOQ-
ROP-SS methods in controlling cardiovascular drugs can be implemented by the 
Jakarta Islamic Hospital to minimize stock inventory, while maintaining the service 
level and can increase the total cost efficiency up to 17,91% of the actual order .  
 
Penyakit kardiovaskuler masih menjadi ancaman global dan berperan besar sebagai 
penyebab kematian nomor satu di dunia. Penderita CVD diharuskan untuk 
mengkonsumsi obat secara rutin sehingga ketersediaan obat tersebut di fasilitas 
kesehatan harus tetap terjaga. Kemudian, obat kardiovaskular merupakan obat dengan 
biaya pemakaian tertinggi selama tahun 2019, yaitu sekitar Rp. 6.924.415.718,20 
(22,62%) sehingga perlu perhatian khusus dalam pengendalian persediaannya. Tujuan 
penelitian ini adalah untuk mengetahui pelaksanaan pengendalian persediaan obat 
kardiovaskular dengan metode ABC-EOQ-ROP-SS untuk meminimalkan total biaya 
persediaan, dengan tetap memperthankan tingkat pelayanan. Penelitian ini 
menggunakan metode komparatif non eksperimental dengan pengumpulan data obat 
kardiovaskular secara retrospektif pada periode Januari - Desember tahun 2019. Data 
diperoleh melalui dokumentasi bagian Instalasi Farmasi dan bagian logistik. Analisis 
data dilakukan untuk mengetahui efisiensi biaya obat kardiovaskular dengan metode 
ABC-EOQ-ROP-SS dibandingkan dengan data aktual pesanan obat tahun 2019.Hasil 
penelitian menunjukkan bahwa pengendalian obat kardiovaskular dengan metode 
ABC-EOQ-ROP-SS diketahui dapat dilaksanakan di Rumah Sakit Islam Jakarta untuk 
meminimalkan stok persediaan, dengan tetap menjaga kinerja pelayanan dan  
meningkatkan efisiensi biaya sekitar 17,91% dari biaya pemesanan aktual. 
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INTRODUCTION 
Cardiovascular disease is still a global threat and give a major role as the number one 
cause of death. In 2015, data from WHO shows that 17.7 million from 39.5 million deaths 
by CVDs (WHO, 2017). In Indonesia, based on data from Basic Health Research in 2018, at 
least 15 out of 1000 people or about 2,784,064 individuals suffer from the disease 
(Riskesdas, 2018). Patients with CVDs should take the medication regularly. Patients with 
cardiovascular disease who withdraw from medication (aspirin) have an increased risk of 
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cardiovascular events > 30% (Sundström et al., 2017). Similar to a previous study, patients 
post myocardial infarction who routinely consumption secondary prevention drugs had 
significantly better event-free survival, with a 27% reduction in risk of MACE (major adverse 
cardiovascular events) (Bansilal et al., 2016). 
Cardiovascular drugs are vital and essential drugs that must be available in the hospital. 
The continuous availability of essential drugs within healthcare facilities plays an important role 
in promoting access and utilization of health services (Kuwawenaruwa, Wyss, Wiedenmayer, 
Metta, & Tediosi, 2020). Drug availability positively affects patient trust in health care 
providers (Shan et al., 2016). Trust in health care providers is important; it shapes health 
service utilization patterns affect treatment compliance (Brennan et al., 2013) and encourages 
communication with service providers (Al-Mandhary, Al-Zakwani, & Afifi, 2007).  
However, hospitals cannot store a large amount of every drug because of limited 
budget. The hospital budget for drugs is the largest component of hospital expenditure. In 
many developing countries, the expenditure on hospital medicines can account for about 40 
to 50% of total hospital cost (Kemenkes, 2016). With the limited budget, hospital has 
tomaintain the drug availability by enhancing inventory control management. Pharmacy 
logistic needs to monitor levels of inventory and determine what levels should be maintained, 
when stock should be replenished, and how large amount should be in order to keep 
inventory cost as minimum as possible while maintaining high customer service level (Jacobs, 
F. R., Chase, R. B., & Aquilano, 2011). 
From the research on inventory control at local hospitals in Bandung, it can be seen 
that the hospital has a potential savings of IDR 829,655,791 (56.93%) of the overstock cost 
of the pharmaceutical unit (Hafnika, F., Farmaciawaty, DA., Adhiutama, A., & Basri, 2016). 
Another study states the optimal inventory control can save up to 10% in the cost of 
administering drug supplies. The operational costs of managing drug supply chain at a 
hospital can reach 40% of the total operating costs, therefore it is very important for a 
hospital to improve its inventory control system (MWise, 2010).  
Research on cytostatic drug inventory control at Moewardi Hospital, Surakarta, in 
2012, controlling cytostatic drugs using the EOQ analysis method is known to increase cost 
efficiency up to Rp. 224,845,245 or 73% of the total inventory cost of Rp. 306,956,410 
(Widodo, 2012) . In the Jakarta Islamic Hospital, drug supply control uses the minimum 
maximum stock level method. Minimum stock for 7 days and maximum for 14 days. 
However, this minimum and maximum stock causes a lot of inventory in warehouses and 
pharmacies. The purpose of this research was to determine the implementation and 
efficiency of controlling cardiovascular drug using the ABC-EOQ-ROP-SS method. 
 
RESEARCH METHOD 
This research is a type of quantitative research using comparative non-experimental 
methods. This study used secondary data of 225 items of cardiovascular drugs during 2019 at 
the Jakarta Islamic Hospital. Data were analyzed to determine the cost efficiency of 
cardiovascular drugs using the ABC-EOQ-ROP-SS method. Result of this research was tested 
using the Paired-Sample t test. This research was done in January – March 2020. At the 
beginning of the research, all cardiovascular drug items were classified according to the ABC 
(Always, Better, Control) classification. The ABC classification use the Pareto Principle, 
which show that a small number of items account for a small rupiah volume and a large 
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number of items account for a small rupiah volume (Hafnika, F., Farmaciawaty, DA., 
Adhiutama, A., & Basri, 2016). ABC method classify inventory based on rupiah volume into 
three categories, which are high rupiah volume (A); moderate rupiah volume (B); low rupiah 
volume (C). For A items typically only 20% of the total items, but account for nearly 70% of 
the total usage. B items typically compose about 30% of the total items and about 20% of the 
total usage. C items account for the remaining 50% of the total items and the remaining 
10% of the total costs. Therefore, A items should be inspected and reorder daily, or near 
daily (Seto, 2004). 
Furthermore, the researcher calculated EOQ (Economic Order Quantity) value in 
category A on the ABC calcification results. EOQ is a formula to determine the number of 
quantity orders that minimizes ordering costs and carrying costs. EOQ (Economic Order 
Quantity) uses the assumption of constant demand, constant waiting time, and fixed order 
costs per order (Waters, 2003). The Economic Order Quantity was calculated using formula: 





𝐸𝑂𝑄 = Economic order quantity 
𝐷 = Annual demand 
O = Ordering cost (Rp/order) 
C = Carrying cost (Rp/unit-year) 
 
After determining the EOQ, the next step is to determine when the purchasing need to 
reorder. Reorder points (ROP) is the limit of the amount of stock that is still there. What needs to be 
taken into account is the time it takes between an order to be placed and the goods are received. At 
that time interval, there must be a guarantee that supplies remain so that they do not interfere with 
service. ROP can calculate using a formula (Peterson & Kelly, 2004): 
 
ROP = (𝑑 𝑥 𝐿) + 𝑆𝑆 
 
Whereas: 
ROP = Re-Order Point 
d = Average demand per period  
L = Lead time 
SS = Safety Stock 
ROP also considers the importance of safety stock to anticipate uncertain demand / 
need. Safety stock is a buffer stock that is stored to accommodate an increase in demand or 
lead time that exceeds the estimated time. Safety stock can be calculated using statistical 
methods with formulas (Waters, 2003): 
SS = 𝑍 𝑥 𝑠𝑑 𝑥 √ 𝐿 
Whereas: 
SS = Safety Stock 
Z = Service level constant 
Sd = Standard deviation of demand 
L = Lead time 
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To determine the efficiency obtained from inventory control of cardiovascular drug, 
the researcher compared the total ordering cost and the total carrying between orders with 
the EOQ method and the actual orders. We can calculate the cost per unit by using formula: 
TC = total reorder costs + total carrying costs = 
      = OD/Q + CQ/2 
Whereas: 
TC = Total Cost 
O = Ordering cost (Rp/order) 
D = Annual Demand 
C = Carrying Cost (Rp/unit-year) 
Q = Quantity Order 
 
RESULT AND DISCUSSION 
Analysis of ABC Investment 
The results of the ABC classification based on investment value of cardiovascular drugs 
are shown in the table I. It’s shows that the results of ABC classification on 225 items of 
cardiovascular drugs obtained category A of 23 drug items (10.22%) with an investment value 
of Rp. 4,839,738,131 (69.89%), category B as many as 38 items of medicine (16.89%) with 
an investment value of Rp. 1,426,359,595 (20.60%), and category B as many as 164 items of 
medicine (72.89%) with an investment value of Rp. 658,317 .992 (9,51%). 
 
Table 1. The results of ABC classification on cardiovascular drugs based on the investment value 
Category Item Cost 
Amount Percentage (%) Amount (IDR) Percentage (%) 
A 23 10,22 4.839.738.131 69,89 
B 38 16,89 1.426.359.595 20,60 
C 164 72,89 658.317.992 9,51  
225 100 6.924.415.718 100 
 
The results of categories A, B and C are directly proportional to the amount of drug 
use by cardiovascular patients at the Jakarta Islamic Hospital. This shows that the drug 
inventory control is less effective and efficient because it is not suitable for drug inventory in 
general. Based on the inventory control delivered by Seto, that category A represents 20% of 
drugs in stock and 70% of total sales (Seto, 2004). Meanwhile, category A in the Jakarta 
Islamic Hospital was only 10.22%. This means that there is an over stock of category A 
cardiovascular drug. 
 
Analysis of Economic Order Quantity (EOQ)  
EOQ calculation is only performed for category A cardiovascular drugs because it is assumed 
that demand for category A drugs is constant. In determining the optimum order quantity 
using the EOQ method, it is necessary to calculate the number of annual demands, ordering 
costs and carrying costs. The annual demand based on data consumption during 2019. 
Ordering cost include costs required to place an order, including telephone fees and 
stationary fees, and employee fee. The carrying cost in this research was calculated using the 
theoretical of Waters, which is 25% of the price unit item of drugs (Waters, 2003). 
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Table.2 Stationary fess per order 
Item Quantity Price (Rp) Total (Rp) 
Paper Cost 13 434.500 5.648.500 
Computer Tape Cost 6 66.000 396.000 
Total Cost/Year     6.044.500 
Total Cost/Month     503.708 
Cost per Order (1200 order)     420 
 
Table.3 Employee Fees 
Employee Fee Nominal (Rp) 
Employee Fee/Month 6.200.000 
Employee Fee Order/hour (150 hours/mounth) 41.333 
Employee Fee per Order (10 minute/order) 6.889 
 
Based on table.2 interviews, the average time needed to place an order is 6 minutes. 
Local call rates are IDR 300 per 3 minutes so the cost for 6 minutes of telephone calls is IDR 
900. Details of stationary fees for each order can be seen in table 2. Based on the order data 
in 2019, the average order per month is 1200 order letters. Each order required duplicate 
paper and computer tape. It takes 1 person on duty to place an order and every month it 
takes 150 hours of work (6 hours of effective work multiplied by 25 days). It takes 10 minutes 
for each order to make so employee fee per order was IDR 6.889.  Based on the table.3 
details of the costs above, the order fee for each order is IDR 8,205. 
After the ordering costs and carrying costs are known, the data is entered into the 
formula. For example, the EOQ calculation for Nitrokaf Retard 2.5 mg BPJS is as follows: 
Annual Demand = 540,898 capsules 
Carrying Cost = 25% x 1,560 = IDR 390, - 
Ordering Cost = IDR 8,209 
Then the Economic Order Quantity (EOQ) is: 
EOQ = √2DO / C 
EOQ = √2 x 540.898 x 8.209 / 390 
EOQ = 4,771 capsules 
 
Table.4 The value of EOQ (Economic Order Quantity) and the frequency of ordering each item of cardiovascular drugs 
category A, compared with the average number of orders and the average order frequency on actual data history 
Drug Name Price/Unit 
Annual 
Demand 











1.560,00 540.898 4.771 9.200 113 60 
Nitrokaf Retad 
Forte 5mg BPJS 
2.401,99 322.236 2.967 6.000 109 55 
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Table.4 (continued) The value of EOQ (Economic Order Quantity) and the frequency of ordering 
each item of cardiovascular drugs category A, compared with the average number of orders and the 
average order frequency on actual data history 
Drug Name Price/Unit 
Annual 
Demand 













1.950 23 56 84 41 
Clopidogrel Tab 
75mg BPJS 
1.403,82 271.639 3.564 7.560 76 38 
Adalat Oros Tab 
30mg BPJS 
3.948,00 93.704 1.248 2.880 75 34 
Candesartan Tab 
16mg BPJS 
943,09 253.142 4.198 6.600 60 39 
Bisoprolol Tab 5mg 
BPJS 
840,67 229.848 4.236 5.880 54 24 
V-Bloc Tab 6,25mg 
BPJS 
1.500,00 123.192 2.322 3.870 53 34 
Candesartan Tab 8mg 
BPJS 
545,00 311.065 6.121 8.640 51 36 
Miozidine Tab 3.740,00 36.874 804 1.020 46 37 
Candesartan Tab 
16mg 
7.150,00 15.212 374 480 41 31 
Norephineprin Inj 
BPJS 




883 24 40 37 16 
Candesartan Tab 8mg 4.500,00 19.642 535 570 37 33 





266 7 14 36 18 
Furosemid Inj 3.410,00 23.148 668 875 35 27 
Nitrokaf Retard 
2,5mg 
2.706,00 28.572 833 1.100 34 21 
Micardis Tab 80mg  24.534,19 3.068 91 240 34 7 
Platogrix Tab 75mg 
(AJI) 
4.400,00 16.983 503 644 34 26 
Clopidogrel Tab 
75mg 
5.536,67 13.471 400 750 34 30 
Canderin Tab 16mg 9.900,00 7.308 220 360 33 21 
Atofar Tab 20mg 12.100,00 5.829 178 240 33 26 
 
In the table.4, this EOQ value was compared with the actual data on quantity drug orders for 
the period January to December 2019.  For example, the number of economical orders for Nitrokaf 
Retard BPJS is 4,771 capsules with a frequency of 113 orders in a period of one year. This means that 
by ordering 4,771 capsules there is an optimal balance between ordering costs and carrying costs so 
that there is an efficiency between the investment value and the cost of drug supplies that must be 
| 243 |                                                               Nopiana1, Atik Nurwahyuni2 – Analysis of Cardiovascular Drugs Inventory … 
 
 
incurred by the hospital. Using the same method, each drug can be determined the EOQ value and 
the frequency of ordering. 
The frequency order of cardiovascular drugs is actually lower than the frequency of 
order of cardiovascular drugs based on the EOQ method. This can increase carrying costs 
even though ordering costs can decrease. The difference in the frequency of reality from 
EOQ shows inefficiency in ordering drug so that it will affect carrying costs. When the 
frequency order is increased, the cost emphasis occurs on carrying costs and reduces the risk 
of damage / expiration, even though the ordering costs increase, but there can be 
considerable cost efficiency (Widodo, 2012). 
 
Analysis of Re-Order Point (ROP) and Safety Stock (SS) 
Even though the number of orders is greater than the EOQ, there is still a possibility of 
a drug vacuum. This is due to the absence of determining the right time to order drugs. So 
that the EOQ value can be combined with the determination of the re-order point by 
considering safety stock. Safety stock is needed to prevent vacancies from occurring due to 
uncertainty in demand, delays in ordering, and delays in transportation when refilling 
(Heizer, 2015). The Safety Stock value and reorder point show in table 5. 
 
Table 5. Economic Order Quantity (EOQ), Reorder Point (ROP), and Safety Stock (SS) 














Nitrokaf Retard 2,5mg BPJS 4.771 113 255 4.822  
Nitrokaf Retad Forte 5mg BPJS 2.967 109 193 2.660  
Diviti PFS 2.5mg/0.5ml BPJS 23 84 2 16  
Clopidogrel Tab 75mg BPJS 3.564 76 200 2.981  
Adalat Oros Tab 30mg BPJS 1.248 75 46 759  
Candesartan Tab 16mg BPJS 4.198 60 99 2.066  
Bisoprolol Tab 5mg BPJS 4.236 54 96 1.779  
V-Bloc Tab 6,25mg BPJS 2.322 53 99 967  
Candesartan Tab 8mg BPJS 6.121 51 155 2.663  
Miozidine Tab 804 46 38 352  
Candesartan Tab 16mg 374 41 20 131  
Norephineprin Inj BPJS 98 39 5 36  
Vascon Inj 24 37 5 14  
Candesartan Tab 8mg 535 37 26 192  
Canderin Tab 8mg 310 36 10 96  
Diviti PFS 2.5mg/0.5ml 7 36 1 3  
Furosemid Inj 668 35 26 206  
Nitrokaf Retard 2,5mg 833 34 42 290  
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Table.5 (Continued) Economic Order Quantity (EOQ), Reorder Point (ROP), and Safety Stock 













Micardis Tab 80mg  91 34 7 31 
Platogrix Tab 75mg (AJI) 503 34 13 150 
Clopidogrel Tab 75mg 400 34 71 209 
Canderin Tab 16mg 220 33 11 66 
Atofar Tab 20mg 178 33 22 67 
 
To calculate safety stock researchers used statistical methods. In calculating the safety 
stock, the service level that the management wants to achieve must be determined. According 
to Waters, the service level used is usually 95%, resulting in a Z value = 1.64. From the 
interviews with the informants, it was found that the lead time of the drugs averaged is 3 
days. Based on table 5, each cardiovascular drug item has a varying ROP. Cardiovascular drug 
orders will only be carried out when stocks reach the ROP point. ROP is a way of procuring 
drugs by considering lead time, safety stock, and the number of needs. Leadtime is used to 
estimate an inventory arrives before the inventory runs out, while safety stock is a safety stock 
to avoid fluctuating demand (Waters, 2003).  
This is an example of calculating the Safety Stock of Nitrokaf Retard 2.5 mg BPJS: 
Annual Demand = 45,671 capsules 
Lead time (l) = 3 days 
Service level = 95% 
Demand per day = 45,671 / 30 days = 1,522 capsules 
Standard deviation of demand per day = 90 capsules 
Z (95%) = 1.65 
Safety Stock = Z × standard deviation of lead-time demand 
= Zσ√L 
= 1.65 x 90 x √3 
= 255 capsules 




Demand per day = 1,522 capsules 
L = 3 days 
SS = 255 capsules 
So, the calculation is: 
ROP = (d x L) + SS 
= (1,522 x 3) + 255 = 4,822 capsules 
So, the Reorder Point (ROP) for Nitrokaf Retard 2.5 mg BPJS is 4,822 capsules 
 
By using the ABC-EOQ-ROP-SS methods is expected to reduce the incidence of cardiovascular 
drug vacancies. The research that conducted by M. Burhan shows a significant influence the EOQ 
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and ROP Methods to reduce frequency of drugs vacancy. He compared the number of drug vacancies 
before and after using the EOQ and ROP methods in drug inventory control, the effects were 
analyzed using the t-test (Burhan, M. Winarsih, Sri Harijanto, 2019).  
 
Analysis of Total Cost Between EOQ and Actual Order 
 
Table 6. The Result of Total Cost Between EOQ and Actual Order 
Drug Name 













      
930.671  
      
930.344  
   
1.861.015  
      
482.634  
   
1.793.998  
   
2.276.632  
Nitrokaf Retad 
Forte 5mg BPJS 
      
891.552  
      
890.839  
   
1.782.391  
      
440.873  
   
1.801.495  




      
695.980  
      
681.884  
   
1.377.864  
      
285.849  
   
1.660.239  




      
625.669  
      
625.402  
   
1.251.071  
      
294.958  
   
1.326.610  
   
1.621.568  
Adalat Oros Tab 
30mg BPJS 
      
616.359  
      
615.888  
   
1.232.247  
      
267.089  
   
1.421.280  




      
495.008  
      
494.884  
      
989.892  
      
314.855  
      
778.045  
   
1.092.900  
Bisoprolol Tab 5mg 
BPJS 
      
445.425  
      
445.136  
      
890.562  
      
320.888  
      
617.895  
      
938.783  
V-Bloc Tab 6,25mg 
BPJS 
      
435.522  
      
435.376  
      
870.899  
      
261.313  
      
725.627  




      
417.176  
      
416.989  
      
834.165  
      
295.548  
      
588.595  
      
884.142  
Miozidine Tab 
      
376.491  
      
375.870  
      
752.361  
      
296.763  
      
476.850  




      
333.891  
      
334.263  
      
668.154  
      
260.157  
      
429.000  




      
316.717  
      
316.528  
      
633.244  
      
193.989  
      
516.780  
      
710.769  
Vascon Inj 
      
302.023  
      
313.500  
      
615.523  
      
181.214  
      
522.500  




      
301.385  
      
300.938  
      
602.323  
      
282.879  
      
320.625  
      
603.504  
Canderin Tab 8mg 
      
298.569  
      
298.375  
      
596.944  
      
257.101  
      
346.500  




      
311.942  
      
283.938  
      
595.880  
      
155.971  
      
567.875  
      
723.846  
Furosemid Inj 
      
284.464  
      
284.735  
      
569.199  
      
217.168  
      
372.969  




      
281.570  
      
281.762  
      
563.332  
      
213.225  
      
372.075  
      
585.300  
Micardis Tab 80mg  
      
276.761  
      
279.076  
      
555.837  
      
104.938  
      
736.026  
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Table 7. (continued) The Result of Total Cost Between EOQ and Actual Order 
Drug Name 











Platogrix Tab 75mg 
(AJI) 
      
277.164  
      
276.650  
      
553.814  
      
216.481  
      
354.200  




      
276.459  
      
276.834  
      
553.292  
      
147.445  
      
519.063  
      
666.508  
Canderin Tab 16mg 
      
272.688  
      
272.250  
      
544.938  
      
166.643  
      
445.500  
      
612.143  
Atofar Tab 20mg 
      
268.822  
      
269.225  
      
538.047  
      
199.376  
      
363.000  
      
562.376  
Total Cost 
   
9.732.308  











Table 8. The difference in total cost between an order by economic order and by actual 
order. 






Order Cost 9.732.308 5.857.357 3.874.951 39,82 
Carrying Cost 9.700.685 17.056.745 -7.356.060 -75,83 
Total Cost 19.432.993 22.914.102 -3.481.109 -17,91 
 
In the table.7, We can see that the total reorder costs equal the total carrying costs in. 
This is always true if we use the economic order quantity. From table 7 it can be seen that 
ordering using the economic order quantity can save costs around 17.91% of the actual 
order. The results obtained differ greatly from the efficiency values obtained from Widodo's 
research which states that using the EOQ analysis method is known to increase the cost 
efficiency of cytostatic drugs by 73% of the total inventory cost. This is because the price per 
item of cardiovascular drug is cheaper than the price per item of cytotoxic drug so that the 
difference in the carrying cost is not too different (Widodo, 2012). 
 
CONCLUSION 
The results of ABC-EOQ-ROP-SS methods in controlling cardiovascular drugs can be 
implemented by the Jakarta Islamic Hospital to minimize stock inventory, while maintaining 
the service level and can increase the total cost efficiency up to 17,91% of the actual order. 
The hospital information system can support in fulfilling the data needed in the calculation 
of the ABC-EOQ-ROP-SS methods. The formula that has been determined must be able to 
be entered into the hospital information system so that stock travel can be evaluated quickly. 
Further research is needed for applicating this method for all of drugs item in Jakarta Islamic 
Hospital. In addition, the carrying costs can be more detailed than this research by calculate 
the electricity costs, storage facility costs, damaged and expired drugs costs, and personnel 








I am grateful to the Director of the Jakarta Islamic Hospital for allowing me to conduct 
research in the hospital pharmacy. 
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